Milestone Pharmaceuticals Inc (MIST) — Capital Reinvestment Ratio

Latest as of June 2021: 0.05x

Milestone Pharmaceuticals Inc (MIST) has a Capital Reinvestment Ratio of 0.05x as of June 2021, meaning it reinvests 0% of its operating cash flow ($1.01 Million) in capital expenditures ($46.00K). See Milestone Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

$1.01 Million

USD

Capital Expenditures

$46.00K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Milestone Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Milestone Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see MIST market cap.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow